Activation of the TGF-β Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients

Figure 3

Effect of transforming growth factor β signaling pathway activation levels on the prognosis of chemotherapy in SCLC patients. (a) K-M survival analysis in the Local-SCLC cohort. (b) K-M survival analysis in the George-SCLC cohort. (c) Univariate and multivariate COX regression models for the Local-SCLC cohort. (d) Univariate and multivariate COX regression models for the George-SCLC cohort.

(a)

(b)

(c)

(d)